Temporal trends of breast cancer burden in the Western Pacific Region from 1990 to 2044: Implications from the Global Burden of Disease Study 2019

[1]  W. Xue,et al.  Burden, trends, and risk factors for breast cancer in China from 1990 to 2019 and its predictions until 2034: an up-to-date overview and comparison with those in Japan and South Korea , 2022, BMC cancer.

[2]  M. J. Germar,et al.  Breast and cervical cancer screening in the Philippines: Challenges and steps forward , 2022, Preventive medicine reports.

[3]  Rajesh Sharma,et al.  Breast Cancer Mortality Trends and Predictions to 2030 and Its Attributable Risk Factors in East and South Asian Countries , 2022, Frontiers in Nutrition.

[4]  Jun Lyu,et al.  Different Trends in the Incidence and Mortality Rates of Prostate Cancer Between China and the USA: A Joinpoint and Age-Period-Cohort Analysis , 2022, Frontiers in Medicine.

[5]  Z. Dai,et al.  Global Burden of Female Breast Cancer: Age-Period-Cohort Analysis of Incidence Trends From 1990 to 2019 and Forecasts for 2035 , 2021, Frontiers in Oncology.

[6]  K. Matsuo,et al.  A Personal Breast Cancer Risk Stratification Model Using Common Variants and Environmental Risk Factors in Japanese Females , 2021, Cancers.

[7]  Ruihua Xu,et al.  Cancer incidence, mortality, and burden in China: a time‐trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020 , 2021, Cancer communications.

[8]  S. Tyrovolas,et al.  Organized breast cancer screening not only reduces mortality from breast cancer but also significantly decreases disability-adjusted life years: analysis of the Global Burden of Disease Study and screening programme availability in 130 countries , 2021, ESMO open.

[9]  Xiaoying Zheng,et al.  Breast Cancer Screening Rates Among Women Aged 20 Years and Above — China, 2015 , 2021, China CDC weekly.

[10]  Tongchao Zhang,et al.  Changing trends in the disease burden of esophageal cancer in China from 1990 to 2017 and its predicted level in 25 years , 2021, Cancer medicine.

[11]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[12]  Dan J Stein,et al.  Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.

[13]  Eun Sug Park,et al.  Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.

[14]  Xinguang Chen,et al.  Historical trends in breast Cancer among women in China from age-period-cohort modeling of the 1990–2015 breast Cancer mortality data , 2020, BMC Public Health.

[15]  A. Karch,et al.  An R package for an integrated evaluation of statistical approaches to cancer incidence projection , 2020, BMC Medical Research Methodology.

[16]  A. Jemal,et al.  The evolving epidemic of breast cancer in sub‐Saharan Africa: Results from the African Cancer Registry Network , 2020, International journal of cancer.

[17]  R. Tamimi,et al.  Public health insurance and cancer‐specific mortality risk among patients with breast cancer: A prospective cohort study in China , 2020, International journal of cancer.

[18]  Longfei Lin,et al.  Incidence and death in 29 cancer groups in 2017 and trend analysis from 1990 to 2017 from the Global Burden of Disease Study , 2019, Journal of Hematology & Oncology.

[19]  B. Larijani,et al.  The association between fat mass and the risk of breast cancer: A systematic review and meta-analysis. , 2019, Clinical nutrition.

[20]  Lutfan Lazuardi,et al.  Family History of Breast Cancer and Breast Cancer Risk between Malays Ethnicity in Malaysia and Indonesia: A Meta-Analysis , 2019, Iranian journal of public health.

[21]  H. Arem,et al.  Adherence to lifestyle-related cancer prevention guidelines and breast cancer incidence and mortality. , 2018, Annals of epidemiology.

[22]  S. Nie,et al.  Trends in incidence and mortality of female breast cancer during transition in Central China , 2018, Cancer management and research.

[23]  T. Okuhara,et al.  Cancer information needs according to cancer type: A content analysis of data from Japan's largest cancer information website , 2018, Preventive medicine reports.

[24]  Melissa Matz,et al.  Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries , 2018, The Lancet.

[25]  S. Kye,et al.  Factors affecting satisfaction with cancer information provided through the social networking services of the National Cancer Information Center in Korea , 2017, Epidemiology and health.

[26]  L. Rubinstein,et al.  CREATE-X a role for capecitabine in early-stage breast cancer: an analysis of available data , 2017, npj Breast Cancer.

[27]  Patrick C. Brennan,et al.  Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence , 2016, Breast Cancer Research and Treatment.

[28]  M. Nojima,et al.  Weight Gain and Alcohol Drinking Associations with Breast Cancer Risk in Japanese Postmenopausal Women - Results from the Japan Collaborative Cohort (JACC) Study. , 2016, Asian Pacific journal of cancer prevention : APJCP.

[29]  I. Gram,et al.  Smoking and Risk of Breast Cancer in a Racially/Ethnically Diverse Population of Mainly Women Who Do Not Drink Alcohol: The MEC Study. , 2015, American journal of epidemiology.

[30]  Chuanhua Yu,et al.  An age-period-cohort analysis of female breast cancer mortality from 1990–2009 in China , 2015, International Journal for Equity in Health.

[31]  A. Hida,et al.  Steroid hormone measurements from different types of assays in relation to body mass index and breast cancer risk in postmenopausal women: Reanalysis of eighteen prospective studies , 2015, Steroids.

[32]  R. Mimoto,et al.  Breast cancer screening and the changing population pyramid of Japan , 2015, Breast Cancer.

[33]  C. la Vecchia,et al.  Alcohol consumption and site-specific cancer risk: a comprehensive dose–response meta-analysis , 2014, British Journal of Cancer.

[34]  T. Misteli,et al.  Common features of chromatin in aging and cancer: cause or coincidence? , 2014, Trends in cell biology.

[35]  Jae-Weon Kim,et al.  Trends in gynecologic cancer mortality in East Asian regions , 2014, Journal of gynecologic oncology.

[36]  Chuanhua Yu,et al.  Age-period-cohort analysis on the cancer mortality in rural China: 1990–2010 , 2014, International Journal for Equity in Health.

[37]  Liying Luo.  Assessing Validity and Application Scope of the Intrinsic Estimator Approach to the Age-Period-Cohort Problem , 2013, Demography.

[38]  M. Coccia.  The effect of country wealth on incidence of breast cancer , 2013, Breast Cancer Research and Treatment.

[39]  Haifa Dbouk,et al.  Epidemiology and prognosis of breast cancer in young women. , 2013, Journal of thoracic disease.

[40]  K. Soo,et al.  Cancer trends and incidences in Singapore. , 2013, Japanese journal of clinical oncology.

[41]  P. Sismondi,et al.  Body mass index (BMI) and breast cancer: impact on tumor histopatologic features, cancer subtypes and recurrence rate in pre and postmenopausal women , 2013, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[42]  A. Jemal,et al.  Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. , 2012, The Lancet. Oncology.

[43]  Wenjiang J. Fu,et al.  The Intrinsic Estimator for Age‐Period‐Cohort Analysis: What It Is and How to Use It1 , 2008, American Journal of Sociology.

[44]  P. Porter,et al.  "Westernizing" women's risks? Breast cancer in lower-income countries. , 2008, The New England journal of medicine.

[45]  Xiaodong Tan,et al.  Physical Activity and Risk of Breast Cancer: A Meta-Analysis of 38 Cohort Studies in 45 Study Reports. , 2019, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[46]  A. Jara-Lazaro,et al.  Breast cancer in Singapore: some perspectives , 2010, Breast cancer.